Effects of periodic breathing on sleep at high altitude: a randomized, placebo‐controlled, crossover study using inspiratory CO 2

Hypoxia at high altitude facilitates changes in ventilatory control that can lead to nocturnal periodic breathing (nPB). Here, we introduce a placebo‐controlled approach to prevent nPB by increasing inspiratory CO 2 and used it to assess whether nPB contributes to the adverse effects of hypoxia on sleep architecture. In a randomized, single‐blinded, crossover design, 12 men underwent two sojourns (three days/nights each, separated by 4 weeks) in hypobaric hypoxia corresponding to 4000 m altitude, with polysomnography during the first and third night of each sojourn. During all nights, subjects’ heads were encompassed by a canopy retaining exhaled CO 2 , and CO 2 concentration in the canopy (i.e. inspiratory CO 2 concentration) was controlled by adjustment of fresh air inflow. Throughout the placebo sojourn inspiratory CO 2 was ≤0.2%, whereas throughout the other sojourn it was increased to 1.76% (IQR, 1.07%–2.44%). During the placebo sojourn, total sleep time (TST) with nPB was 54.3% (37.4%–80.8%) and 45.0% (24.5%–56.5%) during the first and the third night, respectively ( P = 0.042). Increased inspiratory CO 2 reduced TST with nPB by an absolute 38.1% (28.1%–48.1%), the apnoea–hypopnoea index by 58.1/h (40.1–76.1/h), and oxygen desaturation index ≥3% by 56.0/h (38.9.1–73.2/h) (all P < 0.001), whereas it increased the mean arterial oxygen saturation in TST by 2.0% (0.4%–3.5%, P = 0.035). Increased inspiratory CO 2 slightly increased the percentage of N3 sleep during the third night ( P = 0.045), without other effects on sleep architecture. Increasing inspiratory CO 2 effectively prevented hypoxia‐induced nPB without affecting sleep macro‐architecture, indicating that nPB does not explain the sleep deterioration commonly observed at high altitudes. image Key points Periodic breathing is common during sleep at high altitude, and it is unclear how this affects sleep architecture. We developed a placebo‐controlled approach to prevent nocturnal periodic breathing (nPB) with inspiratory CO 2 administration ...